159 related articles for article (PubMed ID: 25001101)
1. Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases.
Rong G; Bai W; Dong Z; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Wang H; Gao X; Chang X; An L; Chen Y; Yang Y
Front Med; 2015 Mar; 9(1):63-71. PubMed ID: 25001101
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
[No Abstract] [Full Text] [Related]
3. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
Vallone P; Catalano O; Izzo F; Siani A
Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series.
Littrup PJ; Aoun HD; Adam B; Krycia M; Prus M; Shields A
Abdom Radiol (NY); 2016 Apr; 41(4):767-80. PubMed ID: 26960728
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria.
Rong G; Bai W; Dong Z; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Wang H; Gao X; Chang X; An L; Li H; Chen Y; Hu KQ; Yang Y
PLoS One; 2015; 10(4):e0123065. PubMed ID: 25849963
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
7. Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy.
Kim GM; Won JY; Kim MD; Park SI; Lee do Y; Shin W; Shin M; Han KH; Kim do Y; Kim SU
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1447-54. PubMed ID: 27256103
[TBL] [Abstract][Full Text] [Related]
8. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intraoperative radiofrequency ablation in management of hepatocellular carcinoma.
Rizk H; Magdy M; Reda M; Alaa T; El-Shafie MM; Ghanem M; Saed T
J Egypt Soc Parasitol; 2008 Dec; 38(3):715-26. PubMed ID: 19209757
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study.
Liu B; Long J; Wang W; Huang T; Xie X; Chen S; Huang G; Jiang C; Ye J; Long H; Xie X; Kuang M
BMC Cancer; 2019 Jul; 19(1):699. PubMed ID: 31311502
[TBL] [Abstract][Full Text] [Related]
13. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
[TBL] [Abstract][Full Text] [Related]
14. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.
Santambrogio R; Podda M; Zuin M; Bertolini E; Bruno S; Cornalba GP; Costa M; Montorsi M
Surg Endosc; 2003 Nov; 17(11):1826-32. PubMed ID: 12802646
[TBL] [Abstract][Full Text] [Related]
16. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization.
Chang NK; Shin SS; Kim JW; Kim HJ; Jeong YY; Heo SH; Kim JK; Kang HK
Korean J Radiol; 2012; 13 Suppl 1(Suppl 1):S104-11. PubMed ID: 22563280
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
20. Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation.
Weber SM; Lee FT
Oncology (Williston Park); 2005 Oct; 19(11 Suppl 4):27-32. PubMed ID: 16366376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
